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Abstract
BACKGROUND: Using sugammadex allows to quickly reverse deep neuromuscular blockade with rocuronium 
in laparoscopic surgery, which results in great benefits during and after surgery by minimizing the problem of 
postoperative residual curarization. 
AIM: The aims of this study are comparing the efficacy of reversing neuromuscular blockade between sugammadex 
and neostigmine and evaluating its unwanted effects after laparoscopic abdominal surgery.
METHODS: Subject of this prospective clinical comparative trial was patients who underwent abdominal laparoscopic 
surgery at 103 Military Hospital from October 2017 to October 2018. Eighty-four patients suffering from abdominal 
laparoscopic surgery under deep neuromuscular blockade were enrolled and divided randomly into two groups 
with 42 patients in each: Group N used neostigmine for neuromuscular blockade reversal and Group S applied 
sugammadex. At the end of surgery, neuromuscular blockade was reversed with either sugammadex or neostigmine.
RESULTS: The reversal time to achieve train-of-four ratio >0.9 in the sugammadex group was 2.42 ± 0.58 min, which 
was shorter than in the neostigmine group (11.83 ± 2.19 min) (p < 0.05). The time until extubation in the sugammadex 
group was 3.69 ± 0.67 min, which was shorter than in the neostigmine group 11.90 ± 2.22 min (p < 0.05). Reversal 
with sugammadex resulted in statistical significance of less sputum production (0% vs. 11.9%), dry mouth (0% vs. 
28.57%), headache (2.38% vs. 7.14%), and nausea (4.76% vs. 14.28%) compared with neostigmine. However, 
26.19% of patients in the neostigmine group presented bradycardia, whereas the concurrent administration of 
atropine in the neostigmine group resulted in increased heart rate.
CONCLUSION: Sugammadex reversed neuromuscular blockade more rapidly and effectively than neostigmine in 
abdominal laparoscopic surgeries. The unwanted effects of sugammadex group were fewer than neostigmine group.
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Introduction
Laparoscopic surgery, particularly laparoscopic 
abdominal surgery, has a large number of advantages, 
such as improving early postoperative ambulation as 
well as reducing complications after surgery. General 
anesthesia is the most commonly applied method for 
laparoscopic surgery. However, the increased intra-
abdominal pressure brings in some limitations because 
of relating to hemodynamic effects.
Neuromuscular blockade plays a crucial 
role in facilitating intubation and optimizing surgical 
conditions during laparoscopic procedures [1]. 
However, if neuromuscular blockade, especially deep 
relaxation, is used to facilitate surgical visualization 
during laparoscopic surgeries, residual neuromuscular 
blockade after surgery is a matter of concern. Residual 
neuromuscular blockade may precipitate adverse 
respiratory events as a consequence of reduced 
minute ventilation or impaired protective airway 
reflexes. An accurate and complete post-operative 
assessment of residual neuromuscular blockade as 
well as the reversal of that blockade (especially deep 
relaxation) plays an important role. Therefore, the use of 
acetylcholinesterase inhibitors (AChEI) or sugammadex 
has been recommended to recover from neuromuscular 
blockade after surgery [2]. Using sugammadex to reverse 
neuromuscular blockade can avoid cardiovascular and 
respiratory effects resulting from AChEIs [3]. Reversing 
deep neuromuscular blockade by sugammadex after 
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abdominal laparoscopic surgery results in great benefits 
during and after surgery by minimizing the problem 
of postoperative residual curarization (PORC). This 
problem is still quite new in Vietnam.
The aims of this study are comparing the 
efficacy and unwanted effect of the reversal of 
neuromuscular blockade with sugammadex and 
neostigmine after laparoscopic abdominal surgery in 
Vietnamese patients. The primary outcomes included 
train-of-four ratio (TOF) ratio (the ratio of T4/T1) at the 
point of time from T0 to T14; duration to achieved TOF 
ratio = 0.5, 0.7, 0.9, and 1; and time of extubation and 
the incidence of side effects (secretion, dry mouth, 
headache, nausea, and bradycardia).
Subjects and Methods
Subjects in this study were patients who 
underwent abdominal laparoscopic surgery for 
cholecystectomy, gastrectomy, hepatectomy, and 
pancreatoduodenectomy at Military Hospital 103 
between October 2017 and October 2018. Exclusion 
criteria included: The age under 18 or above 70 years 
old, liver failure, kidney failure, allergy to rocuronium, 
neostigmine or sugammadex, history of epilepsy, 
mental illness and communication difficulties, coexisting 
neurological complication of diabetes or neuropathy, 
and lack of consent. Patients were also excluded if they 
suffered allergic reactions to any of the drugs or serious 
surgical complications. In this study, 120 patients were 
enrolled and 36 patients were excluded from the study. 
All patients were signed written informed consent 
and this study was carried out in accordance with the 
principles of the Declaration of Helsinki.
In this prospective clinical comparative trial, we 
used the formula: n = 2C/(ES)2 to calculate sample size 
with accepting an α error = 0.01, β error = 0.05, power 
test = 0.95 (95%), C = 19.84 (consulted the table with 
a power test of 95%). ES is the effect size calculated 
according to Glass formula:
1 2 con tro lE S  =  X X /S D-
1X  and 2X  are the mean values of controlled 
and interventional group; SD control is the standard 
deviation of the controlled group estimated, according 
to the previous studies.
According to Gulec et al., the duration of 
neuromuscular blockade reversal by neostigmine 
and sugammadex was 269.1 ± 135.21 s and 130.37 
± 167.29 s, respectively [4]. With that values we had 
n = (2 × 19.84)/(1.026 × 1.026) = 37.7. Thus, there were 
at least 38 cases in each group. In our study, 120 patients 
were collected and 36 patients were excluded from the 
study. There were 84 cases left who were divided into 
two groups: Group N (reversed neuromuscular blockade 
with neostigmine 40 μg/kg and atropine 10 μg/kg, n = 42) 
and Group S (reversed neuromuscular blockade with 
sugammadex 2 mg/kg, n = 42).
Study protocol
Patients were evaluated before surgery 
following standard practices to ensure they were suitable 
and appropriately optimized for the planned procedure. 
In the operating room, an 18-gauge intravenous cannula 
was inserted and standard monitoring (non-invasive 
blood pressure, pulse oximeter, electrocardiography, 
and capnography) was applied. Neuromuscular function 
was started monitoring from induction with TOFscan® 
(IDMed) and the tridimensional sensor pup on the 
adductor pollicis muscle to detect any movements. 
Induction anesthesia was started with the dose of 
fentanyl 3 μg/kg, propofol 2–2.5 mg/kg and rocuronium 
0.6 mg/kg. Tracheal intubation was implemented when 
>95% twitch depression was confirmed. Mechanical 
ventilation was maintained with 8–10 ml/kg tidal 
volumes and a respiratory rate of 12–14 cycles/min. 
Other targeted parameters were peak airway pressures 
of 12–16 cm H2O and EtCO2 of 35–40 mmHg with 
a fresh gas flow of 1.2–2 L/min. During abdominal 
insufflation, these parameters were adjusted to keep 
EtCO2 <40 mmHg and airway pressure <30 cm H2O. 
The CO2 insufflation pump was set at 10 mmHg level.
All patients were performed general anesthesia 
and maintained with sevoflurane. Rocuronium induction 
dose was 0.6 mg/kg for endotracheal intubation and 
additional doses of 0.15 mg/kg were employed when 
the TOF showed ≥1 twitch (If the estimated time 
from the point of injection to the point of abdominal 
closure was <20 min, the rocuronium was not reused). 
Neuromuscular blockade monitor was applied base on 
Good Clinical Research Practice guidelines [5].
TOFscan® (IDMed) monitoring helps to collect 
automatically train-of-four data. According to the 
guideline mentioned above, the onset of neuromuscular 
blockade was defined as the time from the starting of 
intravenous injection of rocuronium to achieving twitch 
depression >95%. Then, intubation conditions were 
assessed with the scoring system as described by the 
Good Clinical Research Practice guidelines [5]. TOF 
ratio was noted after intubation immediately; the post-
tetanic count (PTC) was also counted after obtaining 
TOF ratio. The TOF ratio was monitored every 15 s, and 
PTC was every 3 min to remain a PTC count of 1–2 to 
have a deep blockade. A repeated dose of rocuronium 
0.15 mg/kg was administered to keep TOF and PTC 
in targets. The moderate blockade was defined as a 
level of neuromuscular block with TOF-count ≥1, deep 
blockade was defined as the presence of PTC count ≥ 1 
and TOF count =0, and the intense blockade was defined 
as no response to any pattern of nerve stimulation 
(PTC = 0). Mechanical ventilation was adjusted to keep 
the end‐tidal carbon dioxide concentration between 35 
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and 40 mmHg. Body temperature was maintained at 
the normal range.
When the surgical procedure completed, 
neuromuscular blockade was reversed by either 
sugammadex 2 mg/kg or neostigmine 40 μg/kg 
combined with atropine 10 μg/kg when TOF reached 
2. Until the TOF ratio ≥0.9 and other extubation 
criteria were met such as normal mental; normal skin 
and mucous; cough reflex recovery; and respiratory: 
Spontaneous breath of 10–30 times/min; Vt >5 ml/
kg; circulatory: Systolic blood pressure ≥90 mmHg; 
heart rate ≥60 beats/min; body temperature ≥35°C; 
and no surgical complications, patients’ tracheal 
tube was extubated in the operating room. The level 
of neuromuscular blockade just before injecting the 
reversal agents, and the recovery time (which was 
defined as the time from injecting the reversal agents to 
achieving a TOF ratio of 0.9) was recorded.
Before discharging from the recovery room, all 
symptoms and signs of residual curarization after an 
operation such as episode of hypoxia (SpO2 <95%), 
ability or inability to sustain head-lifting for >5 s, and 
presence of diplopia were assessed. The primary 
outcomes included TOF ratio (the ratio of T4/T1) at the 
point of time from T0 to T14; duration to achieved TOF 
ratio = 0.5, 0.7, 0.9, and 1; and time of extubation and the 
incidence of side effects (secretion, dry mouth, headache, 
nausea, and bradycardia). Baseline characteristics 
(age, weight, height, and ASA), classification of surgery, 
duration of surgery, duration of anesthesia, onset time, 
and recovery time of neuromuscular blockade (time 
from the last dose of rocuronium until the patient was 
transferred to the recovery room), and the total doses of 
rocuronium, neostigmine, atropine, and sugammadex 
were recorded.
Characteristics of reversing neuromuscular 
blockade were measured at 15 time points T0, T1, T2, 
T3, T4, T5, T6, T7, T8, T9, T10, T11, T12, T13, and T14 
as 0 s, 15 s, and 30 s; 1 min, 2 min, 3 min, 4 min, 5 min, 
6 min, 8 min, 10 min, and 20 min; and 1 h, 12 h, and 
24 h after extubation. At the same times, other data 
including temperature, respiratory rate, SpO2, heart 
rate, blood pressure, muscle recurarization (muscle 
recurarization was defined as a decrease in TOF <0.9 
recorded on a TOF scan at any time after the TOF score 
was ≥0.9) and unwanted effects including nausea/
vomiting, secretion, bradycardia, and dry mouth, were 
also recorded.
Statistical analysis
The data were collected, analyzed, and 
processed by medical statistics using SPSS 22.0 
software. Quantitative variables were described as the 
mean ± standard deviation. Discrete variables were 
described in percentages. Student’s t-test was used to 
make a quantitative comparison of averages between 
two-independent distribution groups; ANOVA test was 
used when comparing mean values from different 
groups. The differences between two groups were 
deemed statistically significant when p < 0.05. The 
comparisons between two groups were used to test 
for the Chi-square. Mann–Whitney test was used in a 
comparison of non-distributed variables between two 
groups.
Ethical considerations
This study was approved by the Scientific 
Council of Military Medical University and 103 Military 
hospitals. The study details were explained to patients 
and informed consent obtained before the procedure. 
Sugammadex and neostigmine were used in Vietnam 
with the permission of the Ministry of Health.
Results
The study was carried out on 84 patients 
who were performed abdominal laparoscopic surgery 
and randomly divided into two groups. Baseline 
characteristics were similar in both groups (Table 1: 
Patients demographic and Table 2: Clinical data).
Table 1: Patients demographics
Group Group N (n=42) Group S (n=42) p-value
Age (years) 56.31 ± 12.97 59.64 ± 14.68 0.273
Gender (male/female) 42.9/57.1 33.3/66.7
Height (cm) 159.83 ± 7.85 161.38 ± 8.00 0.372
Weight (kg) 54.19 ± 10.49 55.73 ± 10.82 0.509
BMI (kg/m²) 21.13 ± 3.09 21.27 ± 2.85 0.829
ASA
I/II/III/IV 0/41/1/0 0/39/3/0
Coexisting diseases
Hypertension 6 (14.3) 6 (14.3)
Diabetes 0 (0) 1 (2.4) 0.233
COPD 1 (2.4) 1 (2.4)
Valvular heart 
disease
0 (0) 1 (2.4)
No disease 35 (83.3) 33 (78.5)
Results: mean±SD; analysis by Student’s t-test
The mean TOF value of the sugammadex 
group was higher than that of the neostigmine group at 
all times from 1 to 20 min after reversing neuromuscular 
blockade. The differences were statistically significant 
with p < 0.05. (Table 3: TOF ratio after reversing 
neuromuscular blockade).
Table 2: Clinical data
Group Group N (n=42) Group S (n=42) p-value
Duration of surgery (min) 155.17 ± 50.02 174.52 ± 67.33 0.138
Duration of anesthesia (min) 167.52 ± 51.33 186.69 ± 67.40 0.146
Duration between the last rocuronium 
injection and the end of surgery (min)
30.88 ± 9.88 30.40 ± 9.22 0.818
Fentanyl (μg) 416.67 ± 85.30 403.57 ± 93.96 0.505
Rocuronium (mg) 100.83 ± 18.84 102.62 ± 17.05 0.649
Number of rocuronium doses 3.93 ± 0.81 3.69 ± 0.95 0.216
Types of surgery
Gastrectomy 13 (31.1) 13 (31.1)
Cholecystectomy 10 (23.8) 11 (26.2)
Hepatectomy 0 (0) 2 (4.8) 0.639
Pancreatoduodenoectomy 3 (7.1) 3 (7.1)
Colonoscopy 15 (35.7) 12 (28.6)
Splenectomy 1 (2.4) 1 (2.4)
Results: mean±SD; analysis by Student’s t-test
B - Clinical Sciences Surgery
298 https://www.id-press.eu/mjms/index
The duration to achieve TOF value ≥ 0.5, TOF 
≥ 0.7, TOF ≥ 0.9, and TOF = 1 was significantly shorter 
in Group S than in Group N with p < 0.05. The recovery 
time to achieve the TOF ratio > 0.9 in the sugammadex 
group was 2.42 ± 0.58 min, which was significantly 
shorter than in the neostigmine group (11.83 ± 
2.19 min) (p < 0.05). (Table 4: Results of neuromuscular 
rehabilitation after surgery).
Table 4: Results of neuromuscular rehabilitation after surgery
TOF Group
Group N (n=42) Group S (n=42) p-value
TOF=0.5 (min) 5.62 ± 1.01 1.33 ± 0.38 <0.001*
TOF= 0.7 (min) 7.47 ± 0.95 1.76 ± 0.42 <0.001*
TOF = 0.9 (min) 11.83 ± 2.19 2.42 ± 0.58 <0.001*
TOF = 1 (min) 17.51 ± 3.18 2.92 ± 0.73 <0.001*
*p<0.001 analysis by Student’s t-test. TOF: Train-of-four ratio.
The time until extubation in the sugammadex 
group was 3.69 ± 0.67 min, which was shorter than in the 
neostigmine group 11.90 ± 2.22 min (p < 0.05). (Table 5: 
The variables related to reversing neuromuscular 
blockade).
Table 5: The variables related to reversing neuromuscular 
blockade
Variables Group
Group N (n=42) Group S (n=42) p-value
Time extubation (minutes) 11.90 ± 2.22 3.69 ± 0.67 0.001*
Temperature at reversal neuromuscular 
blockade (°C)
36.49 ± 0.10 36.49 ± 0.12 0.806
Temperature at extubation (°C) 36.51 ± 0.14 36.51 ± 0.13 0.841
Respiratory rate before extubating (rate/
min)
16.67 ± 1.28 16.74 ± 1.39 0.545
Respiratory rate after extubating (rate/
min)
16.97 ± 1.27 16.83 ± 0.93 0.592
*p<0.05 analysis by Student’s t-test.
Regarding unwanted effects, the heart rate 
and blood pressure did not significantly change in the 
sugammadex group. The heart rate was recorded to 
increase in the group using neostigmine and atropine. 
There were 2.38% of patients suffering from headache 
in Group S. Meanwhile, in Group N, 11.90% of patients 
increased sputum production, 28.57% of patients 
suffered from dry mouth symptoms, 7.14% of patients 
had headaches, and 14.28% of patients experienced 
nausea symptoms. There was a significant difference 
between sputum production, dry mouth, and nausea 
symptoms between the two groups with p < 0.05. 
(Table 6: Unwanted effects).
Discussion
An ideal neuromuscular blocking drug should 
have characteristics such as quick onset, short 
duration of action, few muscarinic unwanted effects, no 
accumulation in the body, and especially the ability to 
rapidly recover neuromuscular function after general 
anesthesia with deep neuromuscular blockade. With the 
introduction of sugammadex, this new reversal agent 
allows rapid and complete reversal of neuromuscular 
blockade induced by rocuronium.
In our study, patients’ age was higher than 
those in the study by Wu [6]. In elderly patients, 
anesthesiologists must consider patients’ conditions 
such as reduced physiological function, weakness, 
and coexisting diseases that affect the recovery of the 
respiratory muscles function. Elderly patients were 
at greater risk of PORC, with a longer duration of 
neuromuscular rehabilitation than younger patients [7]. 
Therefore, the assessment of the PORC, as well as the 
relaxation after general anesthesia (especially deep 
relaxation), plays a crucial role in the success of the 
surgery and patient safety.
Prolonged operative duration would be 
affected by the accumulation of rocuronium, the reversal 
of neuromuscular blockade and residual curarization 
after surgery, especially in elderly patients [8]. The 
results in this study had a longer duration of surgery 
than those of Gulec et al., in which operation time was 
105.47 ± 53.38 min [9]. The reason behind this is that 
our study included both gastric and colon surgeries 
which usually require longer operative times. Besides, 
the total dose of drugs was higher than that of Sacan 
et al. [4]. In our study, we used rocuronium at a dose 
of 0.6 mg/kg body weight for endotracheal intubation. 
Elderly patients accounted for a large proportion in our 
study, who have a high rate of PORC due to functional 
impairment [10], [11]. The dose of sugammadex 2 mg/
kg or neostigmine 40 μg/kg plus atropine 10 μg/kg to 
reverse neuromuscular blockade when the second 
stimulus appeared in the TOF stimulus four series 
was used. This dose was similar to other studies on 
residual assessment and restoration [12], [13], [14].
Choosing the time and dose to administer 
muscle relaxant, selecting a method for reversing 
neuromuscular blockade, and evaluating the PORC, 
are very important to ensure safety and avoid 
complications after surgery but which is the best 
Table 3: TOF ratio after reversing neuromuscular blockade
Time Group
Group N (n=42) Group S (n=42) p-value
T0 (%) 0 0
T1 (%) 0 0.50 ± 3.24 0.323
T2 (%) 0.36 ± 2.31 3.88 ± 9.45 0.021*
T3 (%) 1.17 ± 5.28 29.73 ± 20.82 <0.001*
T4 (%) 2.36 ± 8.91 71.59 ± 20.46 <0.001*
T5 (%) 11.95 ± 17.33 97.07 ± 7.36 <0.001*
T6 (%) 25.95 ± 13.09 99.52 ± 3.09 <0.001*
T7 (%) 41.52 ± 12.87 100 <0.001*
T8 (%) 55.59 ± 8.93 100 <0.001*
T9 (%) 73.21 ± 7.84 100 <0.001*
T10 (%) 83.88 ± 6.69 100 <0.001*
T11 (%) 98.69 ± 2.38 100 <0.001*
T12 (%) 100 100
T13 (%) 100 100
T14 (%) 100 100
*p<0.05 analysis by Student’s t-test. TOF: Train-of-four ratio.
Table 6: Unwanted effects
Unwanted effects Group
Group S (n=42) Group N (n=42) p-value
n (%) n (%)
Secretion 0 5 (11.90) 0.045*
Dry mouth 0 12 (28.57) <0.001*
Headache 1 (2.38) 3 (7.14) 0.616
Nausea 2 (4.76) 6 (14.28) 0.265
Bradycardia 0 (0) 11 (26.19) <0.001*
*p<0.05 analysis by Student’s t test.
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TOF-count to reverse neuromuscular blockade with 
neostigmine still is controversial.  The results showed 
that the recovery time of patients receiving a dose of 
2 mg/kg sugammadex was significantly faster than 
those receiving a dose of 40 μg/kg neostigmine and 
atropine 10 μg/kg. The results were similar to the 
study of Geldner et al. on laparoscopic abdominal 
surgery [15] and Jain and Gandhi on laparoscopic 
surgery [16]. Studying on 60 elderly patients 
undergoing cholecystectomy, Yazar et al. showed 
that as age increased, the time from injecting of 
sugammadex to obtaining TOF ratio of 0.9 was 
more than 3.27 min [17]. Slower mean recovery 
time in the elderly than in young patients may be 
a reflection of decreased blood flow to the muscles 
or an increased volume of distribution in elderly 
patients [18], [19]. Although the recovery time of the 
TOF of sugammadex in elderly patients was longer 
than in the younger patients, there was no statistically 
significant difference. Sugammadex rapidly reversed 
neuromuscular blockade induced by rocuronium in all 
age groups, including the elderly [13] and especially 
showed efficacy in the reversal of moderate and deep 
neuromuscular blockade [20].
Average time until endotracheal extubation 
was similar to the result of the study of Gulec et al. when 
comparing the effect of sugammadex and neostigmine 
in reversing rocuronium under general anesthesia with 
desflurane [9].
Neostigmine is a neuromuscular blockade 
reversal agent commonly used in clinical practice. 
It contains a carbamate group that inhibits 
acetylcholinesterase by forming a reversible covalent 
bond to carbamylate the enzyme. Neostigmine agents 
could not reverse neuromuscular blockade when 
the blockade is deep. The discovery of cyclodextrin 
(sugammadex), which effectively reverses deep muscle 
relaxation of non-depolarizing muscle relaxants, 
was very valuable. Sugammadex not only effectively 
reversed muscle relaxation but also shortened the onset 
time, time until extubation, and recovery time [21].
The time until extubation criteria were met 
after reversing neuromuscular blockade in Group S 
was significantly faster than that in Froup N. This 
was demonstrated by the faster recovery time of TOF 
in Group S than that of Group N. The temperature, 
respiratory rate, capillary oxygen saturation, and SpO2 
were not significantly different. The heart rate slightly 
increased in the N group (neostigmine and atropine) 
but did not show statistical significance. Mean blood 
pressure was also no statistically significant different 
between the two groups. These results were in line with 
other research [14], [22].
Neither group in this study included patients 
who suffered from cardiac arrhythmias, bronchospasm, 
or allergy to neostigmine or sugammadex. Most 
unwanted effects were bradycardia, increased sputum, 
dry mouth, headache, nausea, and vomiting. The 
proportion of patients suffering from these unwanted 
effects was similar to other studies [23], [24]. There is 
still no evidence in the literature to blame headache 
and nausea for using sugammadex or neostigmine as 
well because there were many affected factors. That is 
why it needs to have a further study for categorizing this 
regarding.
Conclusion
Reversal of rocuronium in 84 Vietnamese 
patients who underwent abdominal laparoscopic surgery 
by a dose of 2 mg/kg of sugammadex or 40 μg/kg of 
neostigmine combined with 10 μg/kg of atropine showed 
that sugammadex reversed neuromuscular blockade 
more rapidly and effectively than neostigmine. The 
unwanted effects of using sugammadex were fewer 
than neostigmine.
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